Smith Group Asset Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-70
| Closed | -$7K | – | 287 |
|
|
2021
Q4 | $7K | Hold |
70
| – | – | ﹤0.01% | 329 |
|
|
2021
Q3 | $7K | Hold |
70
| – | – | ﹤0.01% | 329 |
|
|
2021
Q2 | $6K | Hold |
70
| – | – | ﹤0.01% | 336 |
|
|
2021
Q1 | $7K | Sell |
70
-1,790
| -96% | -$179K | ﹤0.01% | 289 |
|
|
2020
Q4 | $209K | Hold |
1,860
| – | – | 0.01% | 179 |
|
|
2020
Q3 | $172K | Hold |
1,860
| – | – | 0.01% | 176 |
|
|
2020
Q2 | $145K | Sell |
1,860
-30
| -2% | -$2.34K | 0.01% | 177 |
|
|
2020
Q1 | $111K | Hold |
1,890
| – | – | 0.01% | 204 |
|
|
2019
Q4 | $151K | Hold |
1,890
| – | – | 0.01% | 219 |
|
|
2019
Q3 | $139K | Buy |
1,890
+640
| +51% | +$47.1K | ﹤0.01% | 217 |
|
|
2019
Q2 | $118K | Hold |
1,250
| – | – | ﹤0.01% | 228 |
|
|
2019
Q1 | $100K | Sell |
1,250
-3,400
| -73% | -$272K | ﹤0.01% | 259 |
|
|
2018
Q4 | $251K | Sell |
4,650
-100
| -2% | -$5.4K | 0.01% | 225 |
|
|
2018
Q3 | $371K | Buy |
4,750
+100
| +2% | +$7.81K | 0.01% | 207 |
|
|
2018
Q2 | $295K | Buy |
4,650
+100
| +2% | +$6.34K | 0.01% | 221 |
|
|
2018
Q1 | $417K | Sell |
4,550
-3,700
| -45% | -$339K | 0.01% | 202 |
|
|
2017
Q4 | $622K | Hold |
8,250
| – | – | 0.02% | 194 |
|
|
2017
Q3 | $575K | Buy |
+8,250
| New | +$575K | 0.02% | 208 |
|